Effects of Fufang Xueshuantong Capsule combined with Conbercept on non-proliferative diabetes retinopathy
Objective To explore the clinical efficacy of Fufang Xueshuantong Capsule combined with Conbercept in the treatment of non-proliferative diabetes retinopathy. Methods A total of 104 patients with non-proliferative diabetes retinopathy admitted to Lishui People's Hospital from January 2021 to December 2023 were selected;And these patients were randomly divided into a control group (treated with intravitreal injection of Con-bercept) and a treatment group (treated with intravitreal injection of Conbercept combined with oral Fufang Xueshuantong capsules) according to the random number table method,with 52 cases in each group. Both groups of patients were treated continuously for 3 months. The BCVA,number of microangiomas,bleeding area,exuda-tion,fundus examination results,macular thickness,and adverse reactions were compared between two groups after treatment. Results At 3 months of treatment,there was no statistically significant difference in various indicators between the two groups of patients (P>0.05). The number of BCVA letters in the treatment group was significantly higher than that in the control group,and there was a statistically significant difference ( P<0.05). The number of microangiomas,bleeding area,and exudation in the treatment group were significantly lower than those in the con-trol group after treatment,and there was a statistically significant difference (P<0.05). The OCT test results of pa-tients in the treatment group were significantly better than those of the control group,and there was a statistically significant difference (P<0.05). There was no statistically significant difference in adverse reactions between the two groups after treatment (P>0.05). The clinical efficacy of the treatment group after treatment was significantly higher than that of the control group,and there was a statistically significant difference ( P<0.05). Conclusion Fufang Xueshuantong capsule combined with Conbercept is effective in the treatment of diabetes retinopathy,which can improve the visual acuity of patients with high safety.
Diabetic retinopathyConberceptFu Fang Xue Shuan Tong Jiao Nang
万方数据
维普
